glp-1 cgm and GIP in Type 1 Diabetes Therapy: A Time for Reappraisal? GLP‑1 weight loss you can

Wpywa na zwikszenie wydzielania soku odkowego i reguluje czynnoci trawienne

Dulken, B

Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats

In a real-world analysis of individuals with history of opioid use disorder and alcohol use disorder (AUD), published in Addiction last October, researchers reported that GLP-1 receptor agonists and similar drugs for diabetes and weight-related conditions were associated with a 40% lower rate of opioid overdose and 50% lower rate of alcohol intoxication in people with opioid use disorder and AUDs, respectively

Further study is required to develop the model of surgical AKI, including partial hepatectomy in mice